SavedAdd your journal

Journals / Glokom Katarakt / 2020 / Cilt: 15 - Sayı: 4

Pigmentary Glaucoma Treatment

Ali Ekrem AYDIN
Pages
201–205
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, we will discuss clinical characteristics, pathogenesis and current management of PDS and PG.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pigment dispersion syndrome (PDS) is a clinical entity that is characterized with anomalous irido-zonular contact leading pigment dispersion throughout the anterior segment.
📊
Key Findings & Data:Clinical presentation includes pigmented cells on the corneal endothelium, an increased pigmentation of the trabecular meshwork, and mid-periphery transillumination defects of iris.
💡
Conclusion & Impact:In this review, we will discuss clinical characteristics, pathogenesis and current management of PDS and PG.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Pigment dispersion syndrome (PDS) is a clinical entity that is characterized with anomalous irido-zonular contact leading pigment dispersion throughout the anterior segment. Clinical presentation includes pigmented cells on the corneal endothelium, an increased pigmentation of the trabecular meshwork, and mid-periphery transillumination defects of iris. The syndrome is usually bilateral and more common in myopic individuals and young male adults. Also it can be associated with ocular hypertension or glaucoma. Pigmentary glaucoma (PG) is a kind of secondary open-angle glaucoma and is caused by occlusion of trabecular meshwork by pigmentary cells and reduction in the aqueous humor effl ux. In this review, we will discuss clinical characteristics, pathogenesis and current management of PDS and PG.

🔖

Cite This Article

AYDIN, A. E. (2020). Pigmentary Glaucoma Treatment. Glokom Katarakt, Cilt: 15 - Sayı: 4, 201–205. https://ajindex.com/articles/158877

References (17)

  1. Sugar HS, Barbour FA. Pigmentary glaucoma; a rare clinical entity. Am J Ophthalmol. 1949;32:90-2
  2. Niyandurulupa N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma - a major review. Clin Exp Ophthjalmol 2008;38:868-82
  3. Siddiqui Y, Hulzen RD, Cameron JD, et al. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol 2003;135: 794-9
  4. Campbell DG. Pigmentary dispersion and glaucoma: a new theory. Arch Ophthalmol 1979;97:1667-2
  5. Rodrigues MM, Spaeth GL, Weinreb S, et al. Spectrum of trabecular pigmentation in open-angle glaucoma: a clinicopatologic study. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1976;81:258-76
  6. Lascaratos G, Shah A, Garway-Heath DF. The genetics of pigment dispersion syndrome and pigmentary glaucoma. Surv Ophthalmol 2013; 58:164-75
  7. Campbell DG, Schertzer RM. Pathophysiology of pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol 1995; 6:96-101
  8. Karickhoff JR. Pigmentary dispersion syndrome and pigmentary glaucoma: a new mechanism concept, a new treatment, and a new technique. Ophthalmic Surg 1992; 23:269-77
  9. Pavlin CJ, et al. Accomodation and iridotomy in the pigment dispersion syndrome. Ophthalmic Surg Lasers 1996;27:113- 20
  10. Jensen PK, et al. Exercise and reversed pupillary block in pigmentary glaucoma. Am J Ophthalmol. 1995;120:110-2
  11. Gottanka J, et al. Histologic fi ndings in pigment dispersion syndrome and pigmentary glaucoma. J Glaucoma 2006;15:142-51
  12. Richter CU, et al. Pigmentary dispersion syndrome and pigmentary glaucoma: a prospective study of the natural history. Arch Ophthalmol 1986; 104:211-5
  13. Kingsley O, Vinod K, Gedde SJ. Update on pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol 2017;28:154-60
  14. Mastropasqua L, Carpineto P, Ciancaglini M, Gallenga PE. A 12-month randomised, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Ophthalmology 199;106:550-5 15. Grierson I, Jonsson M, Cracknell K. Latanoprost and pigmentation. Jpn J Ophthalmol 2004;48:602-12
  15. Ritch R, Liebmann J, Robin A et al. Argon laser trabeculoplasty in pigmentary glaucoma. Ophthalmology 1993;100:909-13
  16. Ayala M. Long-term outcomes of selective laser trabeculopalsty (SLT) treatment in pigmentary glaucoma patients. J Glaucoma 2014;23:616-9
  17. Harasymowycz PJ, Papamatheakis DG, Latina M, De Leon M, Lesk MR, Damji KF. Selective laser trabeculoplasty (SLT) complicat